Terbequinil
![]() | |
![]() | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H18N2O3 |
| Molar mass | 274.320 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| | |
Terbequinil (SR-25776) is an experimental chemical compound that has been investigated for modulation of the [[GABAA receptor]]. Public drug and chemistry databases describe it as a quinoline derivative with carboxamide and ether functional groups.[1][2]
The compound has been the subject of preclinical and early clinical investigations but is **not approved** for medical use and has no active marketed indications.[3][4]
See also
References
- ↑ "Terbequinil (SR-25776)". PubChem. Retrieved 14 October 2025.
- ↑ "Terbequinil". NCATS Inxight Drugs. Retrieved 14 October 2025.
- ↑ "Terbequinil". AdisInsight. Springer Nature. Retrieved 14 October 2025.
- ↑ "Terbequinil (SR-25776) — chemical structure". ChemSpider. Retrieved 14 October 2025.

